AI in drug development

Digital

pharmaphorum podcast Episode 176a - Andrew Stelzer, Unlearn.AI

AI in drug development: The real hurdle is implementation

Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.

R&D

Pharma trends and predictions for 2025: An incoming CEO’s pe...

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape.

Digital

pharmaphorum podcast Episode 161a - Isaac Bentwich

From science fiction to reality: AI in drug development

In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI.

R&D

The AI revolution in pharma

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery.

Digital

Abstract red linear visual on a dark background

Deep Dive: AI 2024

In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and

Digital

The evolving role of AI in drug submission and approval: An ...

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes, and reshaping how researchers identify potential drug candid